Nota importante


The pharmacological properties of ergotamine are extremely complex; some of its actions are unrelated to each other, and even mutually antagonistic. The drug has partial agonist and/or antagonist activity against tryptaminergic, dopaminergic and alpha adrenergic receptors depending upon their site, and it is a highly active uterine stimulant. It causes constriction of peripheral and cranial blood vessels and produces depression of central vasomotor centers. The pain of a migraine attack is believed to be due to greatly increased amplitude of pulsations in the cranial arteries, especially the meningeal branches of the external carotid artery. Ergotamine reduces extracranial blood flow, causes a decline in the amplitude of pulsation in the cranial arteries, and decreases hyperperfusion of the territory of the basilar artery. It does not reduce cerebral hemispheric blood flow. Long term usage has established the fact that ergotamine tartrate is effective in controlling up to 70% of acute migraine attacks, so that it is now considered specific for the treatment of this headache syndrome.


peticion de separatas por e-mail



Monografía apta para discapacitados Monografía creada el . Equipo de redacción de IQB (Centro colaborador de La Administración Nacional de Medicamentos, alimentos y Tecnología Médica -ANMAT - Argentina).
Sibir un nivelMapa de esta Web. El mejor sitio para comenzar